These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32924532)

  • 21. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
    Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
    Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model.
    Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J
    Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of voriconazole on population pharmacokinetics and optimization of the initial dose of tacrolimus in children with chronic granulomatous disease undergoing hematopoietic stem cell transplantation.
    Chen X; Wang D; Lan J; Wang G; Zhu L; Xu X; Zhai X; Xu H; Li Z
    Ann Transl Med; 2021 Sep; 9(18):1477. PubMed ID: 34734029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.
    Zhao W; Elie V; Roussey G; Brochard K; Niaudet P; Leroy V; Loirat C; Cochat P; Cloarec S; André JL; Garaix F; Bensman A; Fakhoury M; Jacqz-Aigrain E
    Clin Pharmacol Ther; 2009 Dec; 86(6):609-18. PubMed ID: 19865079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dosing recommendations based on population pharmacokinetics of tacrolimus in Mexican adult patients with kidney transplant.
    Reséndiz-Galván JE; Medellín-Garibay SE; Milán-Segovia RDC; Niño-Moreno PDC; Isordia-Segovia J; Romano-Moreno S
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):303-311. PubMed ID: 30260084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations.
    Liao M; Wang M; Zhu X; Zhao L; Zhao M
    Ther Drug Monit; 2022 Oct; 44(5):615-624. PubMed ID: 36101928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation.
    Yamashita T; Fujishima N; Miura M; Niioka T; Abumiya M; Shinohara Y; Ubukawa K; Nara M; Fujishima M; Kameoka Y; Tagawa H; Hirokawa M; Takahashi N
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):111-8. PubMed ID: 27217047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach.
    Guy-Viterbo V; Baudet H; Elens L; Haufroid V; Lacaille F; Girard M; Debray D; Chardot C; Reding R; Wallemacq P; Musuamba F
    Pharmacogenomics; 2014 Jun; 15(9):1207-21. PubMed ID: 25141896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a population PK model of tacrolimus for adaptive dosage control in stable kidney transplant patients.
    Andreu F; Colom H; Grinyó JM; Torras J; Cruzado JM; Lloberas N
    Ther Drug Monit; 2015 Apr; 37(2):246-55. PubMed ID: 25254416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
    Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
    Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data.
    Chen X; Wang DD; Xu H; Li ZP
    Exp Ther Med; 2020 Aug; 20(2):1423-1430. PubMed ID: 32765671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities?
    Campagne O; Mager DE; Tornatore KM
    J Clin Pharmacol; 2019 Mar; 59(3):309-325. PubMed ID: 30371942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus pharmacokinetics in Hispanic children after kidney transplantation.
    Cherala G; Munar MY; Naher A; Al-Uzri A
    Transplant Proc; 2011 Dec; 43(10):3708-12. PubMed ID: 22172831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.
    Musuamba FT; Guy-Viterbo V; Reding R; Verbeeck RK; Wallemacq P
    Ther Drug Monit; 2014 Feb; 36(1):54-61. PubMed ID: 24081207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.
    Long-Boyle JR; Savic R; Yan S; Bartelink I; Musick L; French D; Law J; Horn B; Cowan MJ; Dvorak CC
    Ther Drug Monit; 2015 Apr; 37(2):236-45. PubMed ID: 25162216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of tacrolimus in pediatric patients with systemic-onset juvenile idiopathic arthritis: Initial dosage recommendations.
    Wang D; Chen X; Xu H; Li Z
    Exp Ther Med; 2019 Dec; 18(6):4653-4660. PubMed ID: 31772640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT.
    Balasubramanian P; Desire S; Panetta JC; Lakshmi KM; Mathews V; George B; Viswabandya A; Chandy M; Krishnamoorthy R; Srivastava A
    Bone Marrow Transplant; 2012 Sep; 47(9):1178-85. PubMed ID: 22231460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.